Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin

We reported a patient with systemic lupus erythematosus complicated by livedoid vasculopathy (LV), who responded well to intravenous immunoglobulin and warfarin. Cutaneous lesions of LV resemble those of cutaneous vasculitis. LV should be included in the differential diagnosis of leg ulcerations eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshioka, Katsunobu, Tateishi, Chiharu, Kato, Hiromi, Chen, Ko‐Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230605/
https://www.ncbi.nlm.nih.gov/pubmed/30455888
http://dx.doi.org/10.1002/ccr3.1803
_version_ 1783370108876357632
author Yoshioka, Katsunobu
Tateishi, Chiharu
Kato, Hiromi
Chen, Ko‐Ron
author_facet Yoshioka, Katsunobu
Tateishi, Chiharu
Kato, Hiromi
Chen, Ko‐Ron
author_sort Yoshioka, Katsunobu
collection PubMed
description We reported a patient with systemic lupus erythematosus complicated by livedoid vasculopathy (LV), who responded well to intravenous immunoglobulin and warfarin. Cutaneous lesions of LV resemble those of cutaneous vasculitis. LV should be included in the differential diagnosis of leg ulcerations even in the presence of autoimmune disorders.
format Online
Article
Text
id pubmed-6230605
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62306052018-11-19 Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin Yoshioka, Katsunobu Tateishi, Chiharu Kato, Hiromi Chen, Ko‐Ron Clin Case Rep Case Reports We reported a patient with systemic lupus erythematosus complicated by livedoid vasculopathy (LV), who responded well to intravenous immunoglobulin and warfarin. Cutaneous lesions of LV resemble those of cutaneous vasculitis. LV should be included in the differential diagnosis of leg ulcerations even in the presence of autoimmune disorders. John Wiley and Sons Inc. 2018-09-12 /pmc/articles/PMC6230605/ /pubmed/30455888 http://dx.doi.org/10.1002/ccr3.1803 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Yoshioka, Katsunobu
Tateishi, Chiharu
Kato, Hiromi
Chen, Ko‐Ron
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
title Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
title_full Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
title_fullStr Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
title_full_unstemmed Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
title_short Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin
title_sort systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: successful treatment with intravenous immunoglobulin and warfarin
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230605/
https://www.ncbi.nlm.nih.gov/pubmed/30455888
http://dx.doi.org/10.1002/ccr3.1803
work_keys_str_mv AT yoshiokakatsunobu systemiclupuserythematosuswithrefractoryulceratedlivedoidvasculopathysuccessfultreatmentwithintravenousimmunoglobulinandwarfarin
AT tateishichiharu systemiclupuserythematosuswithrefractoryulceratedlivedoidvasculopathysuccessfultreatmentwithintravenousimmunoglobulinandwarfarin
AT katohiromi systemiclupuserythematosuswithrefractoryulceratedlivedoidvasculopathysuccessfultreatmentwithintravenousimmunoglobulinandwarfarin
AT chenkoron systemiclupuserythematosuswithrefractoryulceratedlivedoidvasculopathysuccessfultreatmentwithintravenousimmunoglobulinandwarfarin

Ejemplares similares